The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.
Endemicity mapping is required to determining whether a district requires mass drug administration (MDA). Current guidelines for mapping LF require that two sites be selected per district and within each site a convenience sample of 100 adults be tested for antigenemia or microfilaremia. One or more...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-10-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | http://europepmc.org/articles/PMC5643143?pdf=render |
| _version_ | 1818764832275431424 |
|---|---|
| author | Katherine M Gass Heven Sime Upendo J Mwingira Andreas Nshala Maria Chikawe Sonia Pelletreau Kira A Barbre Michael S Deming Maria P Rebollo |
| author_facet | Katherine M Gass Heven Sime Upendo J Mwingira Andreas Nshala Maria Chikawe Sonia Pelletreau Kira A Barbre Michael S Deming Maria P Rebollo |
| author_sort | Katherine M Gass |
| collection | DOAJ |
| description | Endemicity mapping is required to determining whether a district requires mass drug administration (MDA). Current guidelines for mapping LF require that two sites be selected per district and within each site a convenience sample of 100 adults be tested for antigenemia or microfilaremia. One or more confirmed positive tests in either site is interpreted as an indicator of potential transmission, prompting MDA at the district-level. While this mapping strategy has worked well in high-prevalence settings, imperfect diagnostics and the transmission potential of a single positive adult have raised concerns about the strategy's use in low-prevalence settings. In response to these limitations, a statistically rigorous confirmatory mapping strategy was designed as a complement to the current strategy when LF endemicity is uncertain. Under the new strategy, schools are selected by either systematic or cluster sampling, depending on population size, and within each selected school, children 9-14 years are sampled systematically. All selected children are tested and the number of positive results is compared against a critical value to determine, with known probabilities of error, whether the average prevalence of LF infection is likely below a threshold of 2%. This confirmatory mapping strategy was applied to 45 districts in Ethiopia and 10 in Tanzania, where initial mapping results were considered uncertain. In 42 Ethiopian districts, and all 10 of the Tanzanian districts, the number of antigenemic children was below the critical cutoff, suggesting that these districts do not require MDA. Only three Ethiopian districts exceeded the critical cutoff of positive results. Whereas the current World Health Organization guidelines would have recommended MDA in all 55 districts, the present results suggest that only three of these districts requires MDA. By avoiding unnecessary MDA in 52 districts, the confirmatory mapping strategy is estimated to have saved a total of $9,293,219. |
| first_indexed | 2024-12-18T08:08:28Z |
| format | Article |
| id | doaj.art-f149bdacf3994804a3a2197755214da1 |
| institution | Directory Open Access Journal |
| issn | 1935-2727 1935-2735 |
| language | English |
| last_indexed | 2024-12-18T08:08:28Z |
| publishDate | 2017-10-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj.art-f149bdacf3994804a3a2197755214da12022-12-21T21:14:57ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-10-011110e000594410.1371/journal.pntd.0005944The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.Katherine M GassHeven SimeUpendo J MwingiraAndreas NshalaMaria ChikaweSonia PelletreauKira A BarbreMichael S DemingMaria P RebolloEndemicity mapping is required to determining whether a district requires mass drug administration (MDA). Current guidelines for mapping LF require that two sites be selected per district and within each site a convenience sample of 100 adults be tested for antigenemia or microfilaremia. One or more confirmed positive tests in either site is interpreted as an indicator of potential transmission, prompting MDA at the district-level. While this mapping strategy has worked well in high-prevalence settings, imperfect diagnostics and the transmission potential of a single positive adult have raised concerns about the strategy's use in low-prevalence settings. In response to these limitations, a statistically rigorous confirmatory mapping strategy was designed as a complement to the current strategy when LF endemicity is uncertain. Under the new strategy, schools are selected by either systematic or cluster sampling, depending on population size, and within each selected school, children 9-14 years are sampled systematically. All selected children are tested and the number of positive results is compared against a critical value to determine, with known probabilities of error, whether the average prevalence of LF infection is likely below a threshold of 2%. This confirmatory mapping strategy was applied to 45 districts in Ethiopia and 10 in Tanzania, where initial mapping results were considered uncertain. In 42 Ethiopian districts, and all 10 of the Tanzanian districts, the number of antigenemic children was below the critical cutoff, suggesting that these districts do not require MDA. Only three Ethiopian districts exceeded the critical cutoff of positive results. Whereas the current World Health Organization guidelines would have recommended MDA in all 55 districts, the present results suggest that only three of these districts requires MDA. By avoiding unnecessary MDA in 52 districts, the confirmatory mapping strategy is estimated to have saved a total of $9,293,219.http://europepmc.org/articles/PMC5643143?pdf=render |
| spellingShingle | Katherine M Gass Heven Sime Upendo J Mwingira Andreas Nshala Maria Chikawe Sonia Pelletreau Kira A Barbre Michael S Deming Maria P Rebollo The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. PLoS Neglected Tropical Diseases |
| title | The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. |
| title_full | The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. |
| title_fullStr | The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. |
| title_full_unstemmed | The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. |
| title_short | The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. |
| title_sort | rationale and cost effectiveness of a confirmatory mapping tool for lymphatic filariasis examples from ethiopia and tanzania |
| url | http://europepmc.org/articles/PMC5643143?pdf=render |
| work_keys_str_mv | AT katherinemgass therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT hevensime therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT upendojmwingira therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT andreasnshala therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT mariachikawe therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT soniapelletreau therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT kiraabarbre therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT michaelsdeming therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT mariaprebollo therationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT katherinemgass rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT hevensime rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT upendojmwingira rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT andreasnshala rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT mariachikawe rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT soniapelletreau rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT kiraabarbre rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT michaelsdeming rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania AT mariaprebollo rationaleandcosteffectivenessofaconfirmatorymappingtoolforlymphaticfilariasisexamplesfromethiopiaandtanzania |